Neighbourly Pharmacy (NBLY) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisDividendInsider Trades Neighbourly Pharmacy (TSE:NBLY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.55%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)C$1.16 MNumber OfInsiders Selling(Last 12 Months)0 Get NBLY Insider Trade Alerts Want to know when executives and insiders are buying or selling Neighbourly Pharmacy stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBLY Insider Buying and Selling by Quarter Neighbourly Pharmacy Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2024Rx Sidecar GP Inc.InsiderBuy62,500C$18.53C$1,158,350.00 (Data available from 1/1/2013 forward) NBLY Insider Trading Activity - Frequently Asked Questions Who is on Neighbourly Pharmacy's Insider Roster? The list of insiders at Neighbourly Pharmacy includes Rx Sidecar GP Inc., and Stephen Richard Losty. Learn more on insiders at NBLY. What percentage of Neighbourly Pharmacy stock is owned by insiders? 0.55% of Neighbourly Pharmacy stock is owned by insiders. Learn more on NBLY's insider holdings. Which Neighbourly Pharmacy insiders have been buying company stock? The following insider purchased NBLY shares in the last 24 months: Rx Sidecar GP Inc. (C$1,158,350.00). How much insider buying is happening at Neighbourly Pharmacy? Insiders have purchased a total of 62,500 NBLY shares in the last 24 months for a total of C$1,158,350.00 bought. Which Neighbourly Pharmacy insiders have been selling company stock? The following insider sold NBLY shares in the last 24 months: Stephen Richard Losty (C$503,036.70). How much insider selling is happening at Neighbourly Pharmacy? Insiders have sold a total of 28,511 Neighbourly Pharmacy shares in the last 24 months for a total of C$503,036.70 sold. Neighbourly Pharmacy Key ExecutivesMr. Skip Bourdo (Age 46)CEO & Director Compensation: $604.17kMr. Billy Wong C.M.A.CPA, M.B.A., Chief Financial OfficerMr. Jari Pekka Villanen (Age 53)Senior Vice President of Integration, Real Estate & Central Operations Compensation: $307.48kMr. Steve Losty (Age 50)Chief Development Officer Compensation: $302.15kMs. Maura DyerSenior Vice President of People & CultureMs. Alicia Matthews-KentSenior Vice President of Pharmacy Strategy & National OperationsMr. Zev ZelmanCorporate Secretary More Insider Trading Tools from MarketBeat Related Companies WELL Health Technologies Insider Buying Knight Therapeutics Insider Buying Aurora Cannabis Insider Buying Fennec Pharmaceuticals Insider Buying Organigram Insider Buying Canopy Growth Insider Buying Spectral Medical Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (TSE:NBLY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neighbourly Pharmacy Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neighbourly Pharmacy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
